Trials / Completed
CompletedNCT06429514
Study on the Mechanism of Ganoderma Lucidum Spore Powder in the Treatment of Depression
Based on the Theory of Gut-brain Axis, the Intervention Effect and Related Mechanism of Ganoderma Lucidum Spore Powder on Depressive Symptoms in Patients With Thyroid Cancer Were Investigated
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 298 (actual)
- Sponsor
- Ling Zhiqiang · Academic / Other
- Sex
- Female
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
To clarify the clinical effect of Ganoderma lucidum spore powder intervention on postoperative depressive symptoms of papillary thyroid carcinoma ; to elucidate the antidepressant mechanism of Ganoderma lucidum spore powder.
Detailed description
After being informed of the study and potential risks, all patients who gave written informed consent were enrolled. A total of 300 eligible patients were randomly assigned in a double-blind manner and divided into experimental group and control group at a ratio of 2 : 1. The subjects were given oral test drugs ( Ganoderma lucidum spore powder or placebo ) 4g per day for 90 days from the first day after enrollment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Ganoderma lucidum spore powder | One bag at a time, 2 times a day, 2g / bag |
| OTHER | placebo | One bag at a time, 2 times a day, 2g / bag |
Timeline
- Start date
- 2023-03-28
- Primary completion
- 2024-05-03
- Completion
- 2024-05-03
- First posted
- 2024-05-28
- Last updated
- 2024-05-28
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06429514. Inclusion in this directory is not an endorsement.